DAE WOONG KIM: Open Payments
NPI 1386132652 · QUEEN CREEK, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,109 in 65 payments from 16 companies in 2025. Trend: 2023 $539 · 2024 $1,379 · 2025 $1,109
Food & beverage: $1,100Education: $9
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $410 |
| Novo Nordisk Inc | 12 | $211 |
| Lilly USA, LLC | 5 | $89 |
| Astellas Pharma US Inc | 4 | $89 |
| PFIZER INC. | 4 | $63 |
| GlaxoSmithKline, LLC. | 2 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| Renalytix AI, Inc. | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 2 | $18 |
Products named: QULIPTA, Ozempic, CREON, MOUNJARO, Veozah, VRAYLAR, Wegovy, TRELEGY ELLIPTA.
Industry payments across AZ — which companies pay providers there.
